GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by WealthTrust Axiom LLC

WealthTrust Axiom LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,027 shares of the company’s stock after purchasing an additional 194 shares during the period. WealthTrust Axiom LLC’s holdings in GE HealthCare Technologies were worth $311,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in GEHC. Commonwealth Equity Services LLC increased its position in shares of GE HealthCare Technologies by 9.2% in the 3rd quarter. Commonwealth Equity Services LLC now owns 124,500 shares of the company’s stock valued at $8,471,000 after acquiring an additional 10,515 shares during the period. Cambridge Investment Research Advisors Inc. increased its stake in shares of GE HealthCare Technologies by 69.0% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 78,493 shares of the company’s stock valued at $5,341,000 after purchasing an additional 32,051 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its stake in shares of GE HealthCare Technologies by 10.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 103,284 shares of the company’s stock valued at $7,027,000 after purchasing an additional 10,101 shares in the last quarter. Xponance Inc. increased its stake in shares of GE HealthCare Technologies by 8.5% in the 3rd quarter. Xponance Inc. now owns 53,074 shares of the company’s stock valued at $3,611,000 after purchasing an additional 4,154 shares in the last quarter. Finally, Pinnacle Associates Ltd. increased its stake in shares of GE HealthCare Technologies by 55.7% in the 3rd quarter. Pinnacle Associates Ltd. now owns 11,978 shares of the company’s stock valued at $815,000 after purchasing an additional 4,284 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently issued reports on GEHC. Mizuho lifted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price objective for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Citigroup lifted their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. HSBC assumed coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Finally, Morgan Stanley boosted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Stock Down 14.3 %

GEHC stock opened at $76.24 on Wednesday. The firm has a market cap of $34.79 billion, a PE ratio of 25.25, a PEG ratio of 3.09 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The firm’s 50 day moving average price is $88.98 and its 200-day moving average price is $78.75. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting the consensus estimate of $0.90. The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.85 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.